Fuda Cancer Hospital
Immunotherapy for prostate cancer in China typically costs from $19,500 to $45,000. Total expenses depend on the specific drug, cycle count, and hospital tier. Patients save around 68% compared to the US, where this treatment costs $102,500 on average. Standard protocol often includes PD-1 inhibitors, oncologist consultations, and initial diagnostic imaging labs.
Bookimed Expert Insight: Choosing specialized centers in Guangzhou offers a significant value-to-cost ratio. Fuda Cancer Hospital is a prime example, holding JCI accreditation and serving 30,000 international patients. It excels in late-stage cancer care using a combination of immunotherapy and unique technologies like NanoKnife. This integrated approach provides advanced care at a fraction of Western costs.
| China | Turkey | Austria | |
| Immunotherapy for prostate cancer | from $19,500 | from $12,000 | from $30,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for prostate cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for prostate cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for prostate cancer journey.
Day 1
Day 2
Day 3
Day 4
Week 1
Week 2
Week 3
Week 4
Please note that each patient"s experience with Immunotherapy for prostate cancer can vary. The above timeline provides a general guideline but individual cases may differ.
Professor Niu Lizhi is a renowned Chinese cancer doctor, President of Fuda Cancer Hospital, and expert in minimally invasive cryosurgery. He has performed over 10,000 cryosurgeries and 500 NanoKnife procedures, and is the author of over 100 papers in surgical oncology, cryosurgery, and NanoKnife. He is Vice-President of the Asian Society of Cryosurgery and the International Society of Cryosurgery, and a member of the Chinese Medication Association, the China Anti-Cancer Association, the International Hepato-Pancreato-Biliary Association, and the Chinese Society of Integrated Traditional Chinese and Western Medicine.